SB
Insider selling
Shane Barton sold $1.6M of BioAge Labs, Inc. (BIOA) stock
Shane Barton, Principal Accounting Officer of BioAge Labs, Inc. (BIOA), sold 62,566 shares of BIOA stock worth $1.6M, per an SEC Form 4 filed Jul 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 29, 2026, 2 days before it was made public.
BIOA has moved -73.5% since the trade date, from $24.95 to $6.61 (Oct 2, 2026 close).
- Traded
- Jun 29, 2026
- Disclosed
- Jul 1, 2026
- Filing delay
- 2 days
- Price since
- -73.5%
- Role
- Principal Accounting Officer
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.